Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non–small cell lung cancer without tumor PD‐L1 expression: A pooled analysis of 3 randomized controlled trials

Cell Lung Cancer ◽

Pooled Analysis ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

Angiogenesis inhibitors rechallenge in patients with advanced non-small-cell lung cancer: a pooled analysis of randomized controlled trials

OncoTargets and Therapy ◽

10.2147/ott.s88102 ◽

2015 ◽

pp. 2775 ◽

Cited By ~ 3

Author(s):

Quanli Gao ◽

Lingdi Zhao ◽

Wei Li ◽

Huiying Zhang ◽

Nan Hou ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Angiogenesis Inhibitors ◽

Pooled Analysis ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

The benefits and risks of CTLA4 inhibitor plus PD1/PDL1 inhibitor in stage IIIB/IV non‐small cell lung cancer: A systematic analysis and meta‐analysis based on randomized controlled trials

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13465 ◽

2021 ◽

Author(s):

Qiangyun Liu ◽

Zige Fang ◽

Miaowen Liu ◽

Ruoxin Xu ◽

Fengming Yi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

Systematic Analysis ◽

Risk profile of bevacizumab in patients with non-small cell lung cancer: A meta-analysis of randomized controlled trials

Acta Oncologica ◽

10.3109/0284186x.2011.631579 ◽

2011 ◽

Vol 51 (2) ◽

pp. 151-156 ◽

Cited By ~ 9

Author(s):

Chao Cao ◽

Jianmiao Wang ◽

Hansvin Bunjhoo ◽

Yongjian Xu ◽

Huijuan Fang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Risk Profile ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

The Impact of Afatinib on Survival in Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

Journal of Cancer ◽

10.7150/jca.27528 ◽

2019 ◽

Vol 10 (4) ◽

pp. 885-892

Author(s):

Chi Wang ◽

Yun Li ◽

Li Ke ◽

Lejie Cao ◽

Pingsheng Fan ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled ◽

The Impact

Incidence of cardiac toxicities in patients with advanced non-small cell lung cancer treated with osimertinib: A combined analysis of two phase III randomized controlled trials

Annals of Oncology ◽

10.1093/annonc/mdy292.011 ◽

2018 ◽

Vol 29 ◽

pp. viii500 ◽

Cited By ~ 1

Author(s):

K.Z. Thein ◽

S. Swarup ◽

S. Ball ◽

M. Quirch ◽

Y. Vorakunthada ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Controlled Trials ◽

Small Cell Lung ◽

Two Phase ◽

Maintenance erlotinib improves clinical outcomes of unresectable advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials

Experimental and Therapeutic Medicine ◽

10.3892/etm.2012.690 ◽

2012 ◽

Vol 4 (5) ◽

pp. 849-858 ◽

Cited By ~ 3

Author(s):

JIAN ZHANG ◽

WEIQING ZHANG ◽

SHAOHONG HUANG ◽

HUI LI ◽

YUN LI ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Clinical Outcomes ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

Comparison between cisplatin plus vinorelbine and cisplatin plus docetaxel in the treatment of advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials

Molecular and Clinical Oncology ◽

10.3892/mco.2013.210 ◽

2013 ◽

Vol 2 (1) ◽

pp. 146-150 ◽

Cited By ~ 6

Author(s):

GUODONG SHEN ◽

GENG BIAN ◽

HAIYING YU ◽

MIN GAO ◽

DONGMEI KANG ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

Cetuximab-based Therapy is Effective in Chemotherapy-naïve Patients with Advanced and Metastatic Non-small-cell Lung Cancer: A Meta-analysis of Randomized Controlled Trials

Lung ◽

10.1007/s00408-011-9286-3 ◽

2011 ◽

Vol 189 (3) ◽

pp. 193-198 ◽

Cited By ~ 28

Author(s):

Ezzeldin M. Ibrahim ◽

Khaled M. Abouelkhair ◽

Osama A. Al-Masri ◽

Najeeb C. Chaudry ◽

Ghieth A. Kazkaz

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

Risk of adverse events with bevacizumab addition to therapy in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials

OncoTargets and Therapy ◽

10.2147/ott.s96156 ◽

2016 ◽

pp. 2421 ◽

Cited By ~ 1

Author(s):

Han Yang ◽

Xi-Xi Lai ◽

Ren-Ai Xu ◽

Yu-Ping Li

Keyword(s):

Lung Cancer ◽

Adverse Events ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Small Cell Lung ◽

Efficacy and Safety of Sorafenib for Advanced Non-Small Cell Lung Cancer: a Meta-analysis of Randomized Controlled Trials

Asian Pacific Journal of Cancer Prevention ◽

10.7314/apjcp.2014.15.14.5691 ◽

2014 ◽

Vol 15 (14) ◽

pp. 5691-5696 ◽

Cited By ~ 6

Author(s):

Wei-Lan Wang ◽

Zhi-Hui Tang ◽

Ting-Ting Xie ◽

Bing-Kun Xiao ◽

Xin-Yu Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Controlled Trials ◽

Efficacy And Safety ◽

Small Cell Lung ◽